Publication | Closed Access

Longitudinal changes of fractional anisotropy in Alzheimer’s disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study

Neurodegenerative DiseasesAlzheimer's DiseaseLongitudinal ChangesDouble-blinded StudyFractional AnisotropyNeurologyNeuroscienceNeurodegenerationAging-associated DiseaseMedicineGeriatric NeurologyLewy Body Dementia